Strong alliance to help Chinese scientific research and innovation
--- Inno International Research Strategy Cooperation Report
Golden July, passion like fire. Every step is to establish a new level of Inno International research, and it has ushered in an important moment. On July 20, 2018, Inno International Scientific Research and Beijing Biotech Biomedical Technology Co. LTD. officially signed a strategic cooperation agreement. Beijing Biotech Biomedical Technology Co. LTD. is a professional company engaged in product development and scientific research CRO in the field of life sciences. MDL has advanced equipment and has more than 10 years of experience in scientific research and product development. It mainly provides technical services including animal models, molecular biology, immunology, protein science, cell biology and pathological toxic virus. It has established long-term cooperative relationships with Xiehe Hospital, Peking University Medical Department, 301 Hospital, Ocean University, Harbin University of Science and Technology, Shandong University, Chinese Academy of Medical Sciences, Academy of Military Medical Sciences and other research institutions.
At the signing ceremony, the two sides on biomedical big data, international scientific research cooperation, modern biotechnology, high-end scientific research personnel training, international publishing, talent exchange, intellectual property services, according to the development strategy of “application leading, basic breakthrough, coordinated development” ,initially construct a four-level scientific and technological innovation system of research and technology innovation system, international scientific research system, standardized talent training system, and introduction and promotion of new technologies in order to build a quality platform for docking domestic and foreign scientific research resources .
This cooperation is not only conducive to the establishment of a sustained and stable cooperative relationship between the two parties, but also strengthen scientific research exchanges and cooperation between the two sides, promote mutual complementarity of resources and promote the common development of both businesses. It will bring more surprises and possibilities to each other, and make due contributions to international scientific research cooperation and talent introduction, and help improve the scientific research and innovation capabilities of China.